
The acquisition brings Gallant’s experimental stem cell treatments for feline chronic gingivostomatitis and osteoarthritis in dogs and cats into Dechra’s portfolio.
DVM Newsmagazine's presidential poll numbers tilt in favor of McCain, but many veterinarians are still undecided.





